negatives of retatrutide Diagram showing the mechanism action of Retatrutide for weight loss: Study
Description
N Engl J Med 384 , 9891002 (2021)
Additionally, pharmacovigilance analyses using the FDA Adverse Event Reporting System (FAERS) noted an increased number of thyroid-related reports, including hyperplasia and neoplasms, associated with GLP-1 receptor agonists
It is the first GLP-1 receptor agonist available in a tablet form, eliminating the need for injections
"I was anxious and gaining weight, and I couldn't sleep," she recalls
That's by design
